| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c903d8b076caca7cdea3209d30cf0ac3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06Q10-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N7-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-60 |
| filingDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f57b22a00ede4e7d7ddc16a899e81c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62abf4421f5653fbc3b0cf1ef46ddba6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d216ef4df8d9d7e5500a6eba8185d6 |
| publicationDate |
2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017004274-A1 |
| titleOfInvention |
System and method for pharmacovigilance |
| abstract |
A method and system for analyzing a relationship between agents and clinical outcomes is disclosed. The method includes: receiving a selection of one or more agents; receiving a selection of one or more clinical outcomes; for each of the one or more agents, analyzing clinical data stored in a database to determine a number of occurrences of each of the one or more clinical outcomes when the agent is administered; for each of the one or more agents, calculating a risk score for each clinical outcome corresponding to the number of occurrences of the clinical outcome; and outputting the risk scores to a graphical display. The displayed information can also be scaled and filtered for ease of use. Also, the results may be stratified into sub-populations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022407893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10311977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020342375-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018152419-A1 |
| priorityDate |
2013-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |